ARC19499 sodium

• CAT Number: I040110
• Molecular Weight: 11837.60
• Purity: ≥95%

ARC19499 sodium (Cat No.: I040110) is a small-molecule inhibitor designed to target specific enzymes or pathways involved in cancer progression and immune modulation. It works by interfering with key signaling mechanisms that regulate tumor cell growth, survival, and immune evasion. Preclinical studies suggest ARC19499 sodium may have potential in treating various cancers by enhancing the body’s immune response and inhibiting tumor cell proliferation. Its specificity and mechanism of action make it a promising candidate for targeted cancer therapies or combination treatments.

Reference

[1]. Waters EK, Genga RM, Schwartz MC, et al. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. Blood. 2011;117(20):5514-5522.
[Content Brief]

[2]. Gissel M, Orfeo T, Foley JH, Butenas S. Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia. Thromb Res. 2012;130(6):948-955.
[Content Brief]